Angiotensin Receptor Antagonists: all 1,100 studies that test it
Page 1 of 11. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.
- A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy AdultsNot yet recruitingNCT07784621Phase 1
- A Clinical Trial to Evaluate the Drug-drug Interactions of Co-administered 'HUC2-744-A' and 'HUC2-744-B' in Healthy Adult VolunteersNot yet recruitingNCT07784608Phase 1
- Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)Not yet recruitingNCT07735130Phase 4
- Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary InterventionRecruitingNCT07683585Not applicable
- Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke SurvivorsRecruitingNCT07588932Early Phase 1
- Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesEnrolling by invitationNCT07568574Not applicable
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationNCT07547878Phase 4
- Effects of VALsartan On atRIAl Mitral Regurgitation (VALORIA) - PilotRecruitingNCT07539298Phase 2/3
- Investigation of the Effectiveness of Exercise and Anti-Fibrotic Approaches in Frozen ShoulderRecruitingNCT07513350Not applicable
- Manganese-enhanced Magnetic Resonance Imaging in Takotsubo CardiomyopathyRecruitingNCT07491718Not applicable
- Losartan for Corneal FibrosisRecruitingNCT07449000Not applicable
- Vascular Intervention Strategies Trial for Alzheimer'sNot yet recruitingNCT07447206Phase 2
- Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer PatientsNot yet recruitingNCT07370506Phase 1/2
- The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA NephropathyNot yet recruitingNCT07360002Not applicable
- A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and WarfarinRecruitingNCT07331389Phase 1
- Losartan and Paclitaxel in Platinum Resistant Ovarian CancerNot yet recruitingNCT07265739Phase 2
- Sacubitril/Allisartan for Hypertensive Patients With Overweight or ObesityNot yet recruitingNCT07241338Phase 4
- Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated ProteinuriaRecruitingNCT07224776Phase 1
- Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform TrialRecruitingNCT07207057Phase 3
- Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection FractionRecruitingNCT07192341Not applicable
- Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TBNot yet recruitingNCT07160361Phase 4
- TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin TherapyNot yet recruitingNCT07139405Phase 2
- Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) ReconstructionNot yet recruitingNCT07135687Phase 4
- Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.RecruitingNCT07099859Phase 4
- Combined Blood Pressure Medication and Activity Scheduling for Low MoodRecruitingNCT07017023Early Phase 1
- Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia)Not yet recruitingNCT06990204Phase 1
- Losartan to Improve Outcomes After Multi-ligament Knee InjuryRecruitingNCT06933706Phase 2
- Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery DiseaseRecruitingNCT06917664Phase 4
- A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and AdolescentsEnrolling by invitationNCT06863987Phase 3
- Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian CancerRecruitingNCT06815497Phase 2
- Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection FractionNot yet recruitingNCT06712030Phase 3
- Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural TanzaniaRecruitingNCT06704633Phase 4
- To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary HypercholesterolemiaEnrolling by invitationNCT06646354Phase 3
- Losartan and Emotional Processing in Young PeopleRecruitingNCT06636812Early Phase 1
- Losartan and Emotional LearningRecruitingNCT06628154Early Phase 1
- Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic NephropathyNot yet recruitingNCT06501651Phase 4
- Comparison of the Role of Losartan Alone vs Hydrochlorothiazide Plus LosartanNot yet recruitingNCT06491940Not applicable
- Efficacy and Safety of Telmisartan Compared With LosartanRecruitingNCT06431477Phase 4
- Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.RecruitingNCT06364176Phase 2
- Losartan Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking StudyRecruitingNCT06329076Not applicable
- The Effects of Losartan on Attention Control: An Eye-tracking StudyRecruitingNCT06329050Not applicable
- Diuretics vs. Afterload Reduction for Treatment of HeartLogic AlertsRecruitingNCT06218199Phase 4
- Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell CarcinomaRecruitingNCT06211335Phase 1
- The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.RecruitingNCT06208072Not applicable
- Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated TabletsNot yet recruitingNCT06193044Phase 1
- A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)RecruitingNCT06150560Phase 3
- Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using LosartanRecruitingNCT06108063Phase 1/2
- Repurposing Valsartan May Protect Against Pulmonary HypertensionRecruitingNCT06053580Phase 2
- Determination of Drug Levels for Pharmacotherapy of Heart FailureNot yet recruitingNCT06035978Phase 4
- Multi-Omics to Predict the Blood Pressure Response to AntihypertensivesRecruitingNCT05917275Phase 4
- Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer PatientsRecruitingNCT05871333Phase 2
- A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic SyndromeNot yet recruitingNCT05843162Phase 4
- Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain InjuryEnrolling by invitationNCT05826912Phase 2
- The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection FractionRecruitingNCT05508035Phase 3
- Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection FractionRecruitingNCT05487261Phase 4
- Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)RecruitingNCT05465031Phase 4
- Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)RecruitingNCT05321875Phase 3
- Enhancing the Natriuretic Peptide System in HFpEFEnrolling by invitationNCT05279742Phase 1/2
- Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/ValsartanRecruitingNCT05194111Phase 1/2
- Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and HypertensionRecruitingNCT05173025Phase 4
- Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular DiseasesRecruitingNCT05003986Phase 2
- PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm AxisRecruitingNCT04971720Phase 2/3
- Angiotensin Receptor Blockers in Aortic StenosisRecruitingNCT04913870Phase 4
- The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial InfarctionNot yet recruitingNCT04912167Phase 3
- Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.RecruitingNCT04853758Phase 3
- Secondhand Tobacco Smoke and Cardiovascular DiseaseRecruitingNCT04715568Phase 4
- A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A NephropathyRecruitingNCT04663204Phase 2
- Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) StudyRecruitingNCT04191681Phase 4
- Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan StudyEnrolling by invitationNCT03951142Phase 2
- Losartan + Sunitinib in Treatment of OsteosarcomaRecruitingNCT03900793Phase 1
- Effect of Some Drugs on Liver FibrosisRecruitingNCT03770936Phase 3
- Statins and ARBs on Rheumatoid ActivityRecruitingNCT03770702Phase 3
- Intervention for High-normal Blood Pressure in Adults With Type 2 DiabetesRecruitingNCT03264352Phase 4
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaRecruitingNCT02735707Phase 3
- Role of Sympathetic Overactivity and Angiotensin II in PTSD and CVRecruitingNCT02560805Phase 2
- A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 StudyCompletedNCT06149104Phase 3Results posted
- A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgANCompletedNCT05856760Phase 2Results posted
- Sex Differences in the Dilatory Response of Compound 21CompletedNCT05576155Early Phase 1Results posted
- 24 Hour Ambulatory Cardiac Oxygen ConsumptionCompletedNCT05170061Phase 3Results posted
- Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019CompletedNCT04883528Phase 1/2Results posted
- A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood PressureCompletedNCT04668157Phase 3Results posted
- Losartan for Improved Vascular Endothelial Function After PreeclampsiaCompletedNCT04632589Early Phase 1Results posted
- Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of HypertensionCompletedNCT04518306Phase 3Results posted
- Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of HypertensionCompletedNCT04518293Phase 3Results posted
- Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)TerminatedNCT04491136Phase 4Results posted
- Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 PatientsTerminatedNCT04360551Phase 2Results posted
- Stopping ACE-inhibitors in COVID-19CompletedNCT04353596Phase 4Results posted
- Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 InfectionCompletedNCT04340557Phase 4Results posted
- Study of Open Label Losartan in COVID-19CompletedNCT04335123Phase 1Results posted
- Losartan for Patients With COVID-19 Requiring HospitalizationCompletedNCT04312009Phase 2Results posted
- Losartan for Patients With COVID-19 Not Requiring HospitalizationCompletedNCT04311177Phase 2Results posted
- Losartan to Improve Hip MicrofractureTerminatedNCT04212650Phase 1/2Results posted
- Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic CardiomyopathyCompletedNCT04164732Phase 2Results posted
- The ENCHANTMENT HIV StudyCompletedNCT04153136Phase 2Results posted
- Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2CompletedNCT04113109Phase 4Results posted
- Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCCCompletedNCT04023227Phase 4Results posted
- Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)CompletedNCT03988634Phase 3Results posted
- COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart FailureCompletedNCT03917459Phase 3Results posted
- An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.TerminatedNCT03909295Phase 3Results posted
- Telmisartan Pilot Study on Treatment Resistant SchizophreniaTerminatedNCT03868839Phase 2Results posted